Rheumatology

Trials, guidelines and clinical evidence across Rheumatology.

Vaccination in SLE: Lower Immunogenicity and Timing Matter

A review of vaccination in systemic lupus erythematosus examines immune response, flare risk, and when vaccination works best during low disease activity.

By Dr. A. Nikhil Krishnan, MBBS · 4 days ago · 5 min read

Rheumatology·ARD

Peripheral Arthritis Measures in Spondyloarthritis Favor Composite Scores

Trial-based comparison in 13 RCTs found composite scores outperformed single-item tools for peripheral arthritis activity in axSpA and…

4 days ago

Rheumatology·ARD

EULAR 2023 SLE recommendations set tighter steroid and kidney treatment targets

EULAR’s 2023 update for systemic lupus erythematosus favors hydroxychloroquine for all patients, tighter steroid limits, and earlier add-on…

4 days ago

Rheumatology·ARD

Abatacept Response in Early RA Linked to RF and ACPA at 24 Weeks

NORD-STAR data suggest abatacept responded better in RF- and ACPA-positive early rheumatoid arthritis at 24 weeks, but the…

4 days ago

Rheumatology·ARD

Cutaneous signs of inflammasomopathies and their immune mechanisms

Inflammasomopathies can trigger recurrent skin flares, fever, and systemic inflammation. This review outlines lesion patterns, immune drivers, and…

4 days ago

Rheumatology·ARD

Influenza Hospitalization Risk Rises in Inflammatory Joint Disease, Study Finds

Swedish registry data found higher influenza hospitalization and death risks in inflammatory joint disease, largely driven by comorbidities,…

4 days ago

Rheumatology·ARD

Biological therapies for ankylosing spondylitis draw rising research interest

A bibliometric analysis of 2004-2024 research maps rapid growth in biologic therapy studies for ankylosing spondylitis and emerging…

4 days ago

Rheumatology·DailyMed

Naproxen Sodium Label Warns of Cardiovascular and GI Risk

DailyMed’s updated naproxen sodium label reiterates boxed cardiovascular and GI warnings, dosing limits, renal cautions, and pregnancy restrictions.

4 days ago

Rheumatology·ARD

Biosimilars in African rheumatology could expand biologic access

An editorial examines how biosimilars may broaden access to biologic therapy for rheumatic diseases in Africa amid regulatory…

4 days ago

Rheumatology·ARD

Tsai-Fan Yu and the foundations of modern gout management

A profile of Tsai-Fan Yu, the physician-researcher whose work helped shape modern gout management and the clinical approach…

4 days ago

Rheumatology

Trials, guidelines and clinical evidence across Rheumatology.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.